BioSpace News Archive

Tencent Holdings Limited (“Tencent”, 00700.HK), announced today to deepen collaboration with the World Health Organization (WHO).

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV), a life sciences company focused on the research and development of therapeutics for infectious diseases and rare disorders, announced today that it has filed its Pre-Investigational New Drug (“pre-IND”) meeting request with the U.S. Food and Drug Administration (“FDA”) for Bucillamine in the treatment of the coronavirus disease (“COVID-19”).

In light of the rapidly evolving impact of the global pandemic, PTCE’s first three spring conferences will transition to completely virtual events.

In advance of National Healthcare Decisions Day on April 16, VITAS Healthcare offers two tools to help the nation’s physicians and healthcare professionals “have the conversation” with seriously ill patients and families about their goals and options for care.

Move lessens administrative requirements to make it easier for members to get the care they need

The Montreal Heart Institute Foundation is proud to announce that philanthropist Sophie Desmarais will be supporting the Montreal Heart Institute’s research projects thanks to a $1 million donation that will be used by the Research Centre for their ColCorona study.

American Medical Association President Patrice A. Harris, M.D., M.A., will deliver a live national address on Tuesday, April 7, about the essential need for relying on science and data to protect public health, particularly in the face of the COVID-19 pandemic

Prothena Corporation plc announced that in connection with hiring an executive on March 30, 2020, the compensation committee of the Company’s board of directors granted the individual hired by Prothena an option to purchase 120,000 shares of the Company’s common stock.

VIVUS, Inc. (Nasdaq: VVUS; the “Company”), a biopharmaceutical company, today announced the completion of its previously announced registered direct offering of 7,218,750 shares of the Company’s common stock at a purchase price of $1.60 per share for gross proceeds of $11.55 million

SeaSpine Holdings Corporation, a global medical technology company focused on surgical solutions for the treatment of spinal disorders, announced that it has issued inducement awards to nine non-executive employees.